outcome of sub-massive pulmonary thromboemboli in patients who received thrombolytic and or non-thrombolytic therapy

نویسندگان

hasan allah sadeghi rajaie cardiovascular medical and research center, iran university of medical sciences, tehran, ir iran

mona heidarali cardiac electrophysiology research center, rajaie cardiovascular medical and research center, iran university of medical sciences, tehran, ir iran

fusieh faraji rajaie cardiovascular medical and research center, iran university of medical sciences, tehran, ir iran

behshid ghadrdoost rajaie cardiovascular medical and research center, iran university of medical sciences, tehran, ir iran

چکیده

background thrombolytic therapy in patients with sub-massive pulmonary embolism (smpte) needs further assessment. objectives the current study aimed to assess a potential benefit of thrombolytic and non-thrombolytic therapy in patients with smpte. patients and methods one hundred-nineteen patients were enrolled with smpte from 2006 to 2010 in the tertiary care center of rajaie medical and research center. the patients who had pulmonary thromboemboli (pte) and received thrombolytic plus heparin therapy and or non-thrombolytic (unfractionated heparin alone) were evaluated for hemodynamic changes (blood pressure, pulse rate, pulmonary artery systolic pressure, right ventricular failure and right ventricle enlargement), before and after 48 hours of treatment. the mortality rate was also assessed. results forty-five percent of the patients with smpte received thrombolytic therapy (streptokinase) and 55% of smpte patients received non-thrombolytic therapy (unfractionated heparin). pulse rate, pulmonary arterial pressure and tricuspid regurgitation gradient in patients receiving thrombolytic therapy reduced significantly (p = 0.001, p = 0.01 and p = 0.001, respectively). there was no significant difference before and after treatment regarding systolic blood pressure (p = 0.4), diastolic blood pressure (dbp) (p = 0.5), systolic arterial pressure (spap) (p = 0.1), right ventricular (rv) function (p = 0.1) and rv size (p = 0.1). in patients who received a non-thrombolytic therapy, there were no significant differences between the groups regarding sbp (p = 0. 2), dbp ( p= 0. 4) and pr (p = 0. 1), spap (p = 0.6), trg (p = 0.4), rv function (p = 0.4) and rv size (p = 0.2) before and after treatment. there were no significant differences between the groups according to mortality rate. conclusions thrombolytic therapy lead to earlier relief of hemodynamic condition in comparison to non-thrombolytic therapy but no changes were observed in mortality rate.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Outcome of Sub-Massive Pulmonary Thromboemboli in Patients Who Received Thrombolytic and or Non-Thrombolytic Therapy

Background: Thrombolytic therapy in patients with sub-massive pulmonary embolism (SMPTE) needs further assessment. Objectives: The current study aimed to assess a potential benefit of thrombolytic and non-thrombolytic therapy in patients with SMPTE. Patients andMethods: One hundred-nineteen patients were enrolled with SMPTE from 2006 to 2010 in the tertiary care center of Rajaie medical and res...

متن کامل

In-hospital and long-term outcome after sub-massive and massive pulmonary embolism submitted to thrombolytic therapy.

BACKGROUND From a registry of 249 confirmed pulmonary embolism (PE) patients submitted to thrombolytic therapy (TT), we analysed predictors of in-hospital course and long-term mortality. METHODS AND RESULTS The combined clinical end point of in-hospital course associated death, recurrent PE, repeat thrombolysis, surgical embolectomy or bleeding complications. The long-term follow-up included ...

متن کامل

Functional outcome after thrombolytic therapy.

In this paper, we report our experience from a prospective study in 40 ischemic stroke patients admitted during the last two years at University Department of Neurology Stroke Unit, Banja Luka Clinical Center, in order to assess the safety and efficacy of thrombolytic therapy, the impact of age, sex and risk factors, and functional outcome at 6 months of intravenous tissue plasminogen activator...

متن کامل

Thrombolytic therapy in older patients.

OBJECTIVES We compared outcomes following thrombolytic therapy and primary angioplasty with no reperfusion therapy in a population-based cohort of older patients presenting with acute myocardial infarction (AMI) and indications for acute reperfusion. BACKGROUND Evidence supporting the efficacy of acute reperfusion (thrombolytic therapy or primary angioplasty) in the elderly with suspected AMI...

متن کامل

Thrombolytic therapy for patients who wake-up with stroke.

BACKGROUND AND PURPOSE Approximately 25% of ischemic stroke patients awaken with their deficits. The last-seen-normal time is defined as the time the patient went to sleep, which places these patients outside the window for thrombolysis. The purpose of this study was to describe our center's experience with off-label, compassionate thrombolysis for wake-up stroke (WUS) patients. METHODS A ret...

متن کامل

[Thrombolytic therapy of acute pulmonary embolism].

Thrombolytic therapy accelerates the dissolution of acute pulmonary embolism and is potentially lifesaving. The goal of this article is to offer a critical analysis of the use of thrombolytic therapy in this setting. Guidelines have been written and modified and new ones have been published over the past several years. Although an evidence base exists, unanswered questions remain. Despite the p...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
research in cardiovascular medicine

جلد ۵، شماره ۳، صفحات ۰-۰

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023